The Transplant Institute, Sahlgrenska University Hospital, 41345 Gothenburg, Sweden.
Department of Surgery, Institute of Clinical Sciences, Sahlgrenska Academy at the University of Gothenburg, 41345 Gothenburg, Sweden.
Int J Mol Sci. 2022 Oct 8;23(19):11929. doi: 10.3390/ijms231911929.
Acute kidney injury (AKI) is frequent after liver transplantation (LT) and correlates with later development of chronic kidney disease. Its etiology is multifactorial and combines pre-, intra-, and postoperative factors. Additionally, the liver graft itself seems an important element in the development of AKI, yet the detailed mechanisms remain unclear. We hypothesized that grafts of LT recipients developing significant early AKI may show distinct proteomic alterations, and we set out to identify proteome differences between LT recipients developing moderate or severe AKI (n = 7) and LT recipients without early renal injury (n = 7). Liver biopsies obtained one hour after reperfusion were assessed histologically and using quantitative proteomics. Several cytokines and serum amyloid A2 (SAA2) were analyzed in serum samples obtained preoperatively, 2−4 h, and 20−24 h after graft reperfusion, respectively. LT induced mild histological alterations without significant differences between groups but uniformly altered liver function tests peaking on postoperative day 1, with a trend towards more severe alterations in patients developing AKI. Global quantitative proteomic analysis revealed 136 proteins differing significantly in their expression levels (p < 0.05, FC 20%): 80 proteins had higher and 56 had lower levels in the AKI group. Most of these proteins were related to immune and inflammatory responses, host defense, and neutrophil degranulation. No differences between the studied pro- and anti-inflammatory cytokines or SAA2 between groups were found at any moment. Our results suggest that grafts of LT patients who develop early AKI reveal a distinct proteome dominated by an early yet prominent activation of the innate immunity. These findings support the hypothesis that AKI after LT may be favored by certain graft characteristics.
肝移植(LT)后常发生急性肾损伤(AKI),并与慢性肾脏病的后期发展相关。其病因是多因素的,包括术前、术中和术后因素。此外,肝移植物本身似乎是 AKI 发展的一个重要因素,但详细机制尚不清楚。我们假设发生显著早期 AKI 的 LT 受者的移植物可能表现出不同的蛋白质组学改变,我们着手确定发生中度或重度 AKI 的 LT 受者(n = 7)和无早期肾损伤的 LT 受者(n = 7)之间的蛋白质组差异。再灌注后 1 小时获得的肝活检标本进行组织学评估和定量蛋白质组学分析。分别在术前、再灌注后 2-4 小时和 20-24 小时采集血清样本,分析其中的几种细胞因子和血清淀粉样蛋白 A2(SAA2)。LT 诱导轻度组织学改变,但组间无显著差异,但均使肝功能检查在术后第 1 天达到峰值,发生 AKI 的患者改变更严重。全局定量蛋白质组学分析显示,136 种蛋白质的表达水平有显著差异(p < 0.05,FC 20%):AKI 组中 80 种蛋白质表达上调,56 种蛋白质表达下调。这些蛋白质大多与免疫和炎症反应、宿主防御和中性粒细胞脱颗粒有关。在任何时间点,研究的促炎和抗炎细胞因子或 SAA2 之间均未发现组间差异。我们的结果表明,发生早期 AKI 的 LT 患者的移植物显示出明显的蛋白质组,其特征是先天免疫的早期但明显激活。这些发现支持了 AKI 后 LT 可能受某些移植物特征影响的假说。